文献速递中枢神经肿瘤放疗胸部肿瘤放疗

非小细胞肺癌脑转移立体定向放疗后个体化早期死亡与长期生存预测:两个外部验证的列线图

Individualized early death and long-term survival prediction after stereotactic radiosurgery for brain metastases of non-small cell lung cancer: Two externally validated nomograms.
PubMed 文献 · Radiother Oncol · 2017-02-23

本研究基于荷兰四家放疗中心495例接受立体定向放疗(SRS)的有限数目非小细胞肺癌(NSCLC)脑转移患者,开发并外部验证了两个列线图,分别预测早期死亡(<3个月)和长期生存(>12个月)。外部验证中,早期死亡列线图的AUC为0.70,显著优于RPA、DS-GPA、GGS、SIR和Rades 2015的不利组;长期生存列线图的AUC为0.67,显著优于四个模型的有利组(SIR除外)。列线图可个体化评估概率,便于临床使用。

要点

  • 列线图预测早期死亡和长期生存的准确性优于常用预后评分。
  • 预后因素包括WHO体力状态、颅外转移、年龄、最大脑转移灶GTV和性别。
  • 脑转移数目和原发肿瘤控制不是生存的预后因素。

核心结论

  • 列线图对有限数目NSCLC脑转移SRS后的早期死亡和长期生存预测比常用预后评分更准确,并能个体化评估概率。

研究设计与样本

  • 回顾性队列研究,纳入荷兰四家放疗中心495例接受SRS的有限数目NSCLC脑转移患者,分为训练队列(n=214)和外部验证队列(n=281)。

主要发现

  • 生存预后因素为WHO体力状态、颅外转移、年龄、最大脑转移灶GTV和性别,脑转移数目和原发肿瘤控制不是预后因素。
  • 外部验证中,早期死亡列线图AUC=0.70,显著优于RPA、DS-GPA、GGS、SIR和Rades 2015的不利组(AUC范围0.51-0.60,p<0.05)。
  • 长期生存列线图AUC=0.67,显著优于四个模型的有利组(AUC范围0.57-0.61,p<0.05),但除SIR外(AUC=0.64,p=0.34)。

关键数值与推荐

  • 早期死亡定义为<3个月,长期生存定义为>12个月。
  • 预测准确性以受试者工作特征曲线下面积(AUC)定义。

临床怎么用

  • 列线图可用于SRS前个体化评估早期死亡和长期生存概率,辅助临床决策。
  • 模型已在线提供(www.predictcancer.org),便于常规临床使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Commonly used clinical models for survival prediction after stereotactic radiosurgery (SRS) for brain metastases (BMs) are limited by the lack of individual risk scores and disproportionate prognostic groups. In this study, two nomograms were developed to overcome these limitations. METHODS: 495 patients with BMs of NSCLC treated with SRS for a limited number of BMs in four Dutch radiation oncology centers were identified and divided in a training cohort (n=214, patients treated in one hospital) and an external validation cohort n=281, patients treated in three other hospitals). Using the training cohort, nomograms were developed for prediction of early death (<3months) and long-term survival (>12months) with prognostic factors for survival. Accuracy of prediction was defined as the area under the curve (AUC) by receiver operating characteristics analysis for prediction of early death and long term survival. The accuracy of the nomograms was also tested in the external validation cohort. RESULTS: Prognostic factors for survival were: WHO performance status, presence of extracranial metastases, age, GTV largest BM, and gender. Number of brain metastases and primary tumor control were not prognostic factors for survival. In the external validation cohort, the nomogram predicted early death statistically significantly better (p<0.05) than the unfavorable groups of the RPA, DS-GPA, GGS, SIR, and Rades 2015 (AUC=0.70 versus range AUCs=0.51-0.60 respectively). With an AUC of 0.67, the other nomogram predicted 1year survival statistically significantly better (p<0.05) than the favorable groups of four models (range AUCs=0.57-0.61), except for the SIR (AUC=0.64, p=0.34). The models are available on www.predictcancer.org. CONCLUSION: The nomograms predicted early death and long-term survival more accurately than commonly used prognostic scores after SRS for a limited number of BMs of NSCLC. Moreover these nomograms enable individualized probability assessment and are easy into use in routine clinical practice.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Zindler JD, Jochems A, Lagerwaard FJ, et al. Individualized early death and long-term survival prediction after stereotactic radiosurgery for brain metastases of non-small cell lung cancer: Two externally validated nomograms. Radiother Oncol. 2017. PMID: 28237400. doi:10.1016/j.radonc.2017.02.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。